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Abstract
Oxidative stress-mediated neuronal dysfunction is characteristic of several neurodegenerative disorders, including
Parkinson’s disease (PD). The enzyme tyrosine hydroxylase (TH) catalyzes the formation of L-DOPA, the rate-
limiting step in the biosynthesis of dopamine. A lack of dopamine in the striatum is the most characteristic feature of
PD, and the cause of the most dominant symptoms. Loss of function mutations in the PTEN-induced putative kinase
(PINK1) gene cause autosomal recessive PD. This study explored the basic mechanisms underlying the involvement
of pink1 in oxidative stress-mediated PD pathology using zebrafish as a tool. We generated a transgenic line,
Tg(pink1:EGFP), and used it to study the effect of oxidative stress (exposure to H2O2) on pink1 expression. GFP
expression was enhanced throughout the brain of zebrafish larvae subjected to oxidative stress. In addition to a
widespread increase in pink1 mRNA expression, mild oxidative stress induced a clear decline in tyrosine hydroxylase
2 (th2), but not tyrosine hydroxylase 1 (th1) expression, in the brain of wild-type larvae. The drug L-Glutathione
Reduced (LGR) has been associated with anti-oxidative and possible neuroprotective properties. Administration of
LGR normalized the increased fluorescence intensity indicating pink1 transgene expression and endogenous pink1
mRNA expression in larvae subjected to oxidative stress by H2O2. In the pink1 morpholino oliogonucleotide-injected
larvae, the reduction in the expression of th1 and th2 was partially rescued by LGR. The pink1 gene is a sensitive
marker of oxidative stress in zebrafish, and LGR effectively normalizes the consequences of mild oxidative stress,
suggesting that the neuroprotective effects of pink1 and LGR may be significant and useful in drug development.
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Introduction
Parkinson’s disease (PD), a common neurodegenerative
disorder, is characterized by the degeneration of nigrostriatal
dopamine (DA) neurons, a reduction in striatal DA levels and a
decreased DA biosynthetic capacity [1]. Oxidative stress has
been implicated as a factor mediating the initiation and
progression of many neurodegenerative diseases, including
PD. Monogenic variants have been found to be responsible for
nearly 10% of the cases in the familial form of PD [2].
Identification of the familial genes responsible for PD has
revealed novel proteins and pathways that are likely to be
relevant in the pathogenesis of the disease. Current evidence
suggests that mitochondrial insufficiency and oxidative stress
together act as central players in the pathogenesis of both
sporadic and genetic forms of the disease [3-6].
One of the familial genes, PINK1 (PTEN-induced putative
kinase 1), is responsible for PARK6-associated autosomal
recessive PD (ARPD) [7]. It is the second most common gene
after parkin to be responsible for the early onset form of the
disease, and shows considerable variation across different
ethnic groups [8]. PINK1 has been reported to show ubiquitous
expression, but higher expression has been found in the brain,
myocardium of the heart and testes [9,10]. Given its subcellular
localization in the mitochondria and also the cytosol, it is not
surprising that PINK1 plays a role in the normal biology of
mitochondria, including fission and fusion mechanisms [11].
PINK1 is essential for proper mitochondrial function and is
neuroprotective against intrinsic and extrinsic physiological
cellular stress. The loss of PINK1 in mice is associated with
reduced activities of complex I, II, and aconitase, which are
highly sensitive to oxidative stress [12]. Our previous study on
the zebrafish model of PINK1 dysfunction identified HIF
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signaling as one of several significant pathways to be affected
[13]. This reinforced the hypothesis that oxidative stress and/or
hypoxic stress as a consequence of the loss of PINK1 may
lead to PD. It is known that glutathione in the reduced form acts
as an antioxidant [14]. The drug L-Glutathione Reduced (LGR)
has previously been used to rescue some of the defects
caused by PINK1 deficiency [13], but no comprehensive
studies using this model have been carried out. Increased
oxidative stress is the primary mechanism by which
environmental toxins have been associated as potential risk
factors for PD [15]. Tyrosine hydroxylase (TH) catalyzes the
rate-limiting step in the biosynthesis of dopamine and other
catecholamines. Differences have been noted in the
concentration and availability of this enzyme and its cofactors
in disease states such as PD [1]. In PINK1-deficient larval
zebrafish, tyrosine hydroxylase 1 and 2 (th1 and th2) are both
significantly reduced [16].
Taking into account the various genetic tools available to
genetically manipulate the zebrafish genome, we sought to
identify and characterize the zebrafish PINK1 promoter locus to
drive GFP expression using the Tol2 transposition method. The
Tol2 transposon vector has a potential to carry larger inserts
without reducing its transpositional activity, allowing for highly
effective stable integration of exogenous DNA [17]. How
different organisms handle oxidative stress in vivo is poorly
understood. Therefore, by using the wild-type strain, larvae
with pink1 deficiency produced by morpholino oligonucleotides,
and the PINK1 promoter-driven transgenic fish line, we studied
the effect of oxidative stress and evaluated the therapeutic
potential of LGR in this model.
Materials and Methods
Fish maintenance
Zebrafish of the Turku line, used for more than a decade in
experimental work, were used in these experiments because of
their high reproductive capacity and fertility [16,18,19].
Transgenic PINK1 fish were created from this strain of fish.
They were staged in hours post-fertilization (hpf) or days post-
fertilization (dpf) based on [20]. The characterized antisense
morpholino oligonucleotide (MO) from our previously published
paper was used to inhibit PINK1 function [16]. The ethical
permits and approval for the experiments were obtained from
the Regional Government of Southern Finland, numbered
ESAVI/3623/04.10.03/2012.
Tol2 transgenic fish design
Transgenic fish were created by the Tol2 method using a
gateway cloning kit (Invitrogen, Carlsbad, USA). The primers
used for amplifying the gene promoter were as follows:
GGGGACAAGTTTGTACAAAAAAGCAGGCTAATGATGCATC
TCAGTCATTC as the forward primer and
GGGGACCACTTTGTACAAGAAAGCTGGGTCTTTACTGACA
TTTTGAGCCAA as the reverse primer. The primers were
designed to add attB sites to the final product to allow for
insertion into the donor vector pDONR221 when performing the
first reaction step of the gateway cloning. The clone was PCR
verified and the insert was transformed into the destination
vector pXIG-cfos-GW [21], and the sequence was then verified.
The transposase mRNA was made from the pCS-TP vector as
described earlier [22,23]. Both the transposase mRNA and the
donor plasmid were injected into the zebrafish embryos at the
one-cell stage at 25 ng/μl each. We outcrossed the founder fish
(F0) with wild-type fish and collected the progeny embryos
(F1). GFP expression was visualized in the injected embryos,
and three founder fish lines differing in the levels of GFP
expression were identified. One of these founder lines was
chosen based on the maximum GFP expression pattern and
named Tg(pink1:EGFP). These fish were crossed to produce
stable line embryos (F2), which were grown until adults, and
experiments were carried out on the F2 generation onwards.
Immunohistochemistry (IHC)
Embryos of different stages from 3 days post-fertilization
(dpf) until 8 dpf were fixed with 4% PFA overnight at +4 °C.
The samples were washed with PBST 3 x 30 min at RT
followed by a pre-incubation with PBST, 1% DMSO, and 4%
normal goat serum (NGS) for 4 hours to o/n at RT. The anti-
GFP, chicken IgY fraction (Invitrogen, Carlsbad, USA) was
used to stain the transgenic fish at 1:500 dilution o/n in PBST
with 2% NGS at +4 °C. The other antibodies used were those
against tyrosine hydroxylase (TH), PINK1 and 5-hydroxy
tryptophan (5-HT) at 1:1000 dilution (Kaslin and Panula,
2001,Sallinen et al., 2010,Kaslin and Panula, 2001). The
samples were handled and treated as has previously been
described [16].
For brain sections, adult brain samples were dissected and
fixed in 4% PFA overnight, followed by 20% sucrose for the
following incubation overnight at +4 °C. Cryosections were
made by embedding the brain samples in the embedding
matrix, maintaining the section thickness at 25 µm for all the
samples.
Immunofluorescence samples were mounted with 80%
glycerol and examined under a Leica TCS SP2 AOBS confocal
microscope, using an argon laser (488 nm) and green diode
laser (561 nm). The emission wavelength was set to 500–550
nm for Alexa 488 and 600–750 nm for Alexa 561, as described
earlier [24]. Stacks of images were taken at 1.2-µm intervals,
collected by sequential scanning. Frame averaging was carried
out, and the maximum intensity projection algorithm was used
to produce the final images with Leica Confocal Software. In
each individual experiment, samples were scanned using the
same parameters. Pictures were then compiled in Corel Draw
12 software (Corel Corporation, Ottawa, Canada). 3D volume
rendering and the fluorescence intensity measurement was
performed using the Imaris MeasurementPro module in Imaris
6.0 software (Bitplane AG, Zurich, Switzerland). Each of the
IHC experiments included at least 12 individuals per group for
imaging, and each set of experiments was repeated at least
three times.
In situ hybridization (ISH)
The larval fish at 3 dpf, 7 dpf and 8 dpf were fixed with 4%
PFA o/n at +4 °C. The brains were dissected from 7- and 8-dpf-
old larvae and stored in 100% methanol until further use.
Digoxigenin (DIG)-labeled probes were made for th1, th2, dat,
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and pink1 as described earlier [13]. The ISH protocol from
Thisse et al. was used to perform the experiments [25]. Image
analysis was conducted as described earlier [16,26,27].
Chemicals and drug treatment
Hydrogen peroxide (H2O2) (Merck, NJ, USA) was used at a
concentration of 5 µM for 20 min to create oxidative stress
similar to the environment for the studies on wild-type and
transgenic fish. L-Glutathione Reduced (LGR) (G4251) (Sigma-
Aldrich, St. Louis, MO, USA) was used at a concentration of
100 μM for 24 h after H2O2 treatment. The dose and duration of
LGR treatment had been tested and previously used on the
morphants [13]. The samples were washed with E3 fish
medium followed by the application of LGR for 24 hours. They
were then processed for further experimentation.
Q-RT-PCR
RNA samples were isolated from pooled embryos from
untreated and H2O2-treated wild-type fish (30 embryos/sample)
with an RNAEasy minikit (Qiagen) at 3 dpf. RNA was reverse
transcribed to produce cDNA using superscript reverse
transcriptase-III (Invitrogen) primed with oligo (dT) primers
according to the manufacturer’s instructions. Similar
instrumentation and procedures for real-time PCR were
followed as described earlier [13].
Results
Characterization of PINK1 transgene expression
The zebrafish PINK1 gene is located on chromosome 23 and
shares 53% and 54% sequence identity with humans and mice,
respectively, with a highly conserved sequence in the
functional domains. The pink1 transcripts can be detected as
early as 3 hpf and expression persists throughout adulthood
[16]. Several promoter constructs were produced and tested to
identify at least the minimal promoter activity to drive PINK1
expression. A functional promoter construct included a 2-
kilobase fragment of the 5'-flanking region from the
translational start site and contained transcriptional regulatory
sequences that were able to drive strong and ubiquitous GFP
expression after injection into a single-cell embryo. This was
created by the Tol2 transposition vector system [21] (Figure 1
A). In stable Tg(pink1:EGFP) transgenic lines, GFP was
expressed in distinct regions from embryo to adulthood. The
highest expressing regions were visualized in the brain, heart,
liver and muscle by IHC on whole-mount fish embryos with
GFP antibodies (Figure 1B-C). From the dorsal side of the
intact brain, it was apparent that PINK1 GFP expression
marked the mid-hindbrain boundary (MHB) (Figure 1D).
Although low-level transgene expression showed a ubiquitous
expression pattern, there were areas of higher expression in
the brain. Analysis of the brain regions showed the highest
GFP expression in the telencephalon (Tel), optic tectum (TeO),
thalamus (T), and in discrete regions of the hypothalamus and
rhombencephalon (rho) (Figure 1E-F). The GFP expression
often colocalized with the PINK1-ir, suggesting that expression
of the transgene follows the endogenous pink1 expression
pattern (Figure 2). The overlap was consistent with our
previously published study on PINK1 [16]. The expression
pattern in the brain at 7 dpf was compared with the pattern of
TH immunoreactivity (ir) and 5-HT-ir (Figure 1). Although
overlap in some of the cells was seen with TH and 5-HT
immunoreactive regions, it was not apparent in all the cells
(Figure S1 A–F). Transgene expression in the larval and adult
brain sections was analyzed and a schematic representation of
the highly apparent PINK1 transgene expression in zebrafish
brain was prepared, as shown in Figure S2 A.
Oxidative stress
To investigate the role of stress in PINK1 regulation, we used
the transgenic line as well as wild-type larvae. The transgenic
larvae and the wild-type larvae were subjected to a mild heat
shock or treated with 5 μM H2O2. Changes in transgene
expression were observed by performing IHC with the GFP
antibody, and in wild-type fish, gene expression was detected
by ISH and transcript levels were measured by q-RT-PCR. To
determine whether Tg(pink1:EGFP) reflects pink1 responses to
oxidative stress, we subjected the transgenic larvae to a very
low concentration of H2O2 for 20 min and fixed the larvae to
perform IHC with GFP antibodies. The PINK1 transgenic larvae
showed an increase in GFP-expressing cells in the whole brain
compared to the control fish without treatment (Figure 3 A–C).
This effect was reduced in the presence of the drug L-
Glutathione Reduced (LGR). The change in expression levels
of the transgene was pronounced. We therefore created a 3D
image using the ImarisMeasurementPro module in Imaris
software (Bitplane) and visualized the volume of cells
expressing the transgene in different planes. The apparent
increase in transgene expression in certain regions of the brain
could be easily visualized by the 3D representation. The
volume of GFP-expressing cells in the H2O2-treated group was
considerably larger than that of control brain and LGR-treated
brain samples from the Tg(pink1:EGFP) line (Figure 3 D–F).
Increased expression was evident in the telencephalon and
midbrain, extending to the hindbrain. The mean fluorescence
intensities of the groups were measured and mapped in a
graphical manner, as shown in Figure 3 G. The
Tg(pink1:EGFP) fish were subjected to heat shock, but no
effect on the expression levels of the transgene was observed
(data not shown). We then analyzed the effect of H2O2
treatment on TH-ir in dopaminergic neuron groups and found
no differences between the control and H2O2-treated fish
(Figure 3 H-I). However, the monoclonal antibody used only
identifies the TH1 protein and not the TH2 protein [26]. No
significant differences were detected in dat (dopamine
transporter) expression as observed by q-RT-PCR and ISH
(Figure S3).
To examine whether H2O2 treatment affected th2 expression,
we studied the transcript levels of th2, pink1, and th1 by q-RT-
PCR in wild-type larvae at 3 dpf (Figure 4 A–C). A decrease in
th2 and an increase in pink1 transcripts were detected, while
no change occurred in th1 levels. These effects were also
rescued by LGR administration, as revealed by q-RT-PCR. The
Turku strain wild-type larvae were subjected to H2O2 at 7 dpf,
and the effect of LGR on th2 and pink1 expression was studied
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Figure 1.  The PINK1 promoter construct and expression pattern in zebrafish larva of the Tg(pink1:EGFP) line.  A.
Construction of the PINK1 promoter DNA fragment comprising the sequence -2 kb upstream of the 5’ end of the pink1 gene and
including the ATG start site. This is inserted in the cloning site in the Tol2 transposon vector pCS-cfosGFP, which contains a small
intronic sequence and a GFP expression cassette having minimal cfos activity [21]. B-F. Confocal z-stack images of the whole-
mount Tg(pink1:EGFP) larval stages.
B. GFP expression as observed in peripheral tissues at different stages of development by GFP IHC. In a lateral view of 4 dpf whole
mount larvae, expression was observed in the heart (H) and liver (L); anterior to the left.
C. Expression in the muscle of the 4-dpf larvae in a lateral view (M); anterior to the left.
D. The whole mount GFP expression at 5 dpf; dorsal views, anterior to the top, showing pronounced immunoreactive cells in brain
regions such as the telencephalon (Tel), mid-hindbrain boundary (MHB) and rhombencephalon (rho).
E- F. Dorsal and ventral views of the brain of 7-dpf Tg(pink1:EGFP) fish; anterior to the right.
E. In the ventral view, the strongest GFP expression is seen in the telencephalon (Tel), anterior part of optic tectum (TeO), thalamus
(T), and the lateral rhombencephalon (rho). F. The dorsal view shows the prominent expression in the mid-hindbrain boundary
(MHB) along with Tel and rho.
Scale bar represents 100μm. GFP – Green fluorescent protein, PINK1 – PTEN-induced putative kinase 1.
doi: 10.1371/journal.pone.0081851.g001
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at 8 dpf. In situ hybridization was performed at 7 dpf, because
changes in th2 levels could be monitored effectively in all the
individual cell groups expressing th2. In agreement with the q-
RT-PCR results, the signal intensities of th2 were reduced in
the H2O2-treated groups, and were rescued by LGR (Figure 4
D–F).
Effect of the drug LGR on pink1 morphants
The loss of dopaminergic neurons is a characteristic feature
of PD. In zebrafish, the dopaminergic system has been
visualized by TH immunoreactivity. Following the identification
of the second th gene, we have focused on the differential
expression of th1 and th2 in the current study. Our previous
study on pink1 revealed that LGR was an effective drug that
could normalize erythropoiesis in pink1-deficient fish [13]. Here,
we utilized the same drug regime to treat the pink1 morphants
and to study the effects on th1 and th2 expression, which was
decreased in the morphants, as reported earlier at 3 dpf [16].
In our previous study, using the same pink1 MO, we
demonstrated that th1 expression declined in the morphants in
the cell group complex of 5,6,11, which represents the preoptic,
thalamic and pre-tectal nucleus in the diencephalon [28]. This
cluster of neurons has also been named as the ventral
diencephalic group (vDC) [29]. In the current study, we
subjected the wild-type fish to pink1 MO, standard MO, and co-
injected a group with pink1 MO and pink1 mRNA, and
examined the effect of LGR on the expression of th1 and th2
(Figure 5). The loss of group 5,6,11, representing th1 neurons
Figure 2.  A-C. The PINK1-ir colocalizes with the GFP expression pattern in the brain of 7-dpf fish from the transgenic line
in most parts of the brain. Colocalization was visualized in the telencephalon (arrow), the thalamic region (*), and the
rhombencephalon (arrowhead).  D-L. Representative higher magnification images from adult brain sections (25 µm) for PINK1-ir
and GFP-ir. D-F represents the telencephalic region in the saggital plane. G-I represents the thalamic region, and J-L represents the
rhombencephalic region from the coronal plane. GFP – Green fluorescent protein, PINK1 – PTEN-induced putative kinase 1, ir –
Immunoreactivity.
doi: 10.1371/journal.pone.0081851.g002
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in pink1 morphants, was rescued by pink1 mRNA, as has been
observed by ISH (Figure 5 A–C). The effect was verified by q-
RT-PCR (Figure 5 D). The effect of LGR on morphants slightly
increased th1 expression in the pink1 morphants (Figure 5 E–
G). LGR treatment could also rescue the th1 amacrine cells,
which lost visible expression, in the retina of the morphants and
partially in the pre-tectal region (Figure 5 B and F). In the
rescue group (Figure 5 F), the additive effect of pink1 mRNA
and LGR enhanced th1 expression to a larger magnitude than
that seen in the standard MO group, as was quantified by q-
RT-PCR (Figures 5 H).
We analyzed th2 expression patterns in the standard MO,
pink1 MO and pink1 MO + pink1 mRNA co-injected samples
without treatment (Figure 5 I–K) and with LGR treatment
(Figure 5 M–O). LGR improved th2 expression in the pink1
morphants in the dopaminergic cell group 10b (as defined in
[26]), and the effect of the drug with pink1 mRNA was stronger
than that of pink1 mRNA alone (Figures 5 K, O). The loss of
th2 expression has been verified in the morphants by q-RT-
PCR (Figure 5 L). The drug LGR was quite effective for th2 cell
group enrichment, as can also be seen from the q-RT-PCR
results (Figure 5 P).
Discussion
The goal of this study was to develop and validate a
transgenic model that will help in the interpretation of the
precise function of the PINK1 in vivo, and to study the effects of
oxidative stress and PINK1 dysfunction on th genes. Our data
objectively demonstrate that oxidative stress significantly
downregulates th2 in distinct neuronal cell populations and
upregulates pink1 in larval zebrafish. Both effects were
normalized by treatment with L-Glutathione Reduced. Reduced
glutathione could also rescue, along with pink1 mRNA, both th1
and th2 expressing cell populations, which were lost in pink1
morphants.
Figure 3.  The effect of H2O2 on GFP and TH1 expression in Tg(pink1:EGFP) larval fish.  A-C. GFP-ir at 7 dpf in the zebrafish
larvae. GFP-ir increases in the H2O2-treated fish (B) as compared to the control fish (A). The effect is rescued in the LGR treated
fish (C).
D. Mean fluorescence intensity values of the WT, H2O2-treated group and the H2O2+LGR treated group. A significant change in the
H2O2-treated group was observed (p < 0.01).
E-G. A three-dimensional image to perform volume rendering was constructed using the Imaris MeasurementPro module in Imaris
software for the above-mentioned fish at a similar threshold intensity. The changes indicated as the changed total volume of the
representative images for control (E), H2O2 (F) and LGR-treated fish (G). Scale bar represents 80 μm.
H-J. TH-ir is unchanged among the control (H), H2O2-treated (I) and H2O2 together with LGR (J) groups of larval fish. No change in
the pretectal (7) and preoptic, thalamic or pre-tectal nucleus (5,6,11) cell populations was seen. Other visible groups in the olfactory
bulb and ventral telencephalic nuclei (1,2), periventricular hypothalamus and posterior tuberculum (13), and the locus coeruleus (14)
also displayed no change in TH-ir.
Scale bar represents 100 μm. A-C and H-J. H2O2 – Hydrogen Peroxide, GFP – Green fluorescent protein, ir – immunoreactivity,
LGR – L-glutathione reduced, PINK1 – PTEN-induced putative kinase 1, TH – tyrosine hydroxylase.
doi: 10.1371/journal.pone.0081851.g003
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The existing experimental evidence strongly suggests that
PINK1 protects neurons against oxidative stress and also
neurotoxins. In neuroblastoma cells treated with toxins such as
staurosporine and MG132, PINK1 overexpression suppresses
toxin-induced damage [30,31]. The development of the
transgenic line for PINK1 provided us with a tool to visualize
and characterize the dynamic changes in its expression in live
zebrafish. The Tg(pink1:EGFP) line provided strong transgene
expression that was integrated into the germline and sustained
over several generations. Even though PINK1 is ubiquitously
expressed, transgene expression was apparently higher in
some regions than others. It has not been ruled out that the
patterns we see could be attributed to the lack of some
regulatory elements in the 2 kilobase genomic segment used in
this study. This needs to be taken into account in future use of
this fish line. This phenomenon with ubiquitous promoters for
genes such as ubi and β-actin has previously shown that these
promoters, with strong expression during development,
gradually become silenced and restricted to certain cell groups,
and are not expressed in others [32,33]. This is either due to
random integration into the genome or due to special cell type-
specific functions. Analysis of the detailed expression pattern of
PINK1 in zebrafish has been lacking. In the mouse and rat,
PINK1 mRNA is expressed unevenly in neurons of the cortex,
striatum, thalamus, brainstem, and cerebellum [34]. In humans,
PINK1 expression is highest in the hippocampus, substantia
nigra and cerebellar Purkinje cells [35]. We have reported the
expression in different brain regions with PINK1 antibody [16],
Figure 4.  In-situ hybridization and q-RT-PCR at 3dpf in wild type fish following treatment with H2O2 and H2O2+LGR.  A. The
th2 transcript levels significantly decreased in the H2O2 treated samples, verified by q-RT-PCR.
B. The pink1 transcript levels increased significantly in the H2O2 treated as compared to wild type samples.
C. No significant change in the th1 transcript levels was detected between the groups. Only a declining trend was observed.
Unpaired t-test (* p-value < 0.05, ** p-value< 0.01).
D-F. The expression of th2 mRNA is reduced in group 10b of the 7-dpf H2O2-treated fish as compared with untreated control fish. In
the LGR-treated groups at 8 dpf, the decrease in th2 mRNA expression was prevented. The th2-expressing neuron groups 3b, 8b,
9b, 10b are identified according to [26].
Scale bar represents 100 μM. th1 – tyrosine hydroxylase1, th2 – tyrosine hydroxylase 2, pink1 – PTEN-induced putative kinase 1.
doi: 10.1371/journal.pone.0081851.g004
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Figure 5.  Expression levels of th1 and th2 mRNA at 3 dpf in pink1 morphants untreated and treated with LGR.  A-C. Altered
th1 expression in the untreated std ctrl MO, pink1MO, and pink1MO+mRNA groups. A decrease in th1 expression in the population
5,6,11 (*) in morphants (B) was observed as compared to the ctrl MO group (A). The expression could be rescued by pink1 mRNA
co-injection (C).
D. Representative quantitative graph for the untreated group.
E-G. The expression of th1 ISH in LGR-treated groups. The drug LGR rescued the reduced th1 cells in the eyes and also group
5,6,11 of the morphants (E) as compared to the ctrl MO group (D). The expression is enhanced in the rescue group with the
combined effect of LGR and pink1 mRNA (F).
H. Graphical representation of the transcript levels for th1 in the LGR-treated group. A significant change in the pink1 mRNA co-
injected group.
I-K. The expression of th2 ISH in the untreated std MO, pink1MO, and pink1MO+mRNA groups. A loss of th2 was observed in group
10b in the pink1 morphants (H) as compared to ctrl MO (G). The pink1 mRNA rescued th2 expression in group 10b (I).
L. The representative th2 transcript levels determined by q-RT-PCR for the untreated group.
M-O. The expression of th2 ISH in LGR treated groups. LGR-treated pink1 MO shows a slight increase in the th2 10b group (K) as
compared to ctrl MO (J). The pink1 mRNA along with LGR completely rescues the loss of th2 in the 10b cell group (L).
P. Representative q-RT-PCR results for the th2 LGR-treated group. A significant change in the pink1 mRNA co-injected group
together with LGR significantly increased the th2 transcript levels.
Figures D and L present confirmation of th1 and th2 transcripts downregulation in the pink1 morphants. Figures H and P present the
additive rescue effect of LGR together with pink1 mRNA on the morphants.
The Bonferroni Hochberg multiple comparison statistical test was applied for the q-RT-PCR results (* p < 0.05, ** p < 0.01, *** p <
0.001). ISH – in-situ hybridization, LGR – L-glutathione reduced, MO – morpholino oligonucleotides, pink1 – PTEN-induced putative
kinase 1, q-RT-PCR – quantitative real-time PCR, th1 – tyrosine hydroxylase1, th2 – tyrosine hydroxylase 2.
Scale bar represents 100 μm.
doi: 10.1371/journal.pone.0081851.g005
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and in the transgenic fish we were able to visualize the
expression pattern throughout their development and confirm
the ubiquitous expression pattern in the vast majority of cell
types by GFP IHC. Apparently higher expression was observed
in the telencephalon, anterior part of optic tectum, thalamus,
rhombencephalon, and mid-hindbrain boundary in the larval
and adult brain sections. The expression pattern of the
transgene was very similar to the pink1 fish pattern, which
indicated that the transgenic fish recapitulate endogenous gene
expression. The pink1 promoter is not expressed at same level
in all cell types. These effects are anticipated for these
randomly integrated transgene constructs [32].
Effect of H2O2 on the transgenic fish line
Based on previous studies in different cell lines, PINK1 has
neuroprotective activity, most likely by antagonizing
mitochondrial dysfunction caused by oxidative stress and
neurotoxins [30]. PINK1 overexpression in the neuroblastoma
cell line SHSY5Y could rescue cell death caused by
neurotoxins [31]. Postmortem investigations of PD patients and
findings from studies using the selective nigral toxin MPTP
have revealed increased iron levels, decreased levels of
reduced glutathione (GSH), and impaired mitochondrial
function [15], which supports the hypothesis that oxidative
stress contributes to nigral cell degeneration in PD.
Administration of H2O2 leads to similar damage in different
strains of zebrafish [36]. The free radical generator H2O2 has
been used in the oxidative stress model of PD in the SHSY5Y
cell line as an in vitro model [37]. Pink1 overexpression
protects cells against oxidative stress, which is achieved by
TRAP1 phosphorylation [38]. The H2O2 treatment concentration
in this study was selected based on previous studies, which
have reported that doses below 150 μM are safe for zebrafish
embryos and cause no abnormalities [39]. Therefore, we
decided to use a very low concentration (5 μM) of H2O2 for
treatment that would have no deleterious effects on the normal
fish phenotype or behavior, but could possibly still trigger a
physiological stress response. This concentration was indeed
sufficient to alter the expression pattern of pink1 in the
transgenic line, and pink1 and th2 in the wild-type fish, but it
was not enough to significantly disrupt the transcript levels of
th1. In summary, th2 together with pink1 was more sensitive to
H2O2 than th1.
Differential regulation of the catecholaminergic
systems
We could see that TH-ir, which mostly detects th1 [26], did
not change considerably in H2O2-treated samples, while th2
mRNA levels declined. This result was also confirmed by q-RT-
PCR, in which the th2 gene was significantly downregulated,
while the th1 transcript did not show any significant changes.
The two th genes have been known to show differential
regulation in teleosts [40]. Additional studies have been
performed using different markers for the dopaminergic
system, which have revealed that th2 neurons are dopamine-
synthesizing cells, in addition to th1 cells [29,41]. Dopamine
cells are very vulnerable to slight changes in oxygen, because
TH is the rate-limiting enzyme in catecholamine synthesis and
requires oxygen as its cofactor. Therefore, low levels of cellular
oxygen or environmental oxygen would affect the levels of both
th genes. In zebrafish, th2 is known to be more vulnerable to
slight changes in oxygen than th1 [42]. In this study, the
applied concentration of H2O2 was quite low and did not
significantly affect the th1 levels, but was sufficient to alter th2
levels. A recently published paper stated that th2 had
tryptophan hydroxylase-like activity [43]. Independent
verification has not been published and this question was not
addressed in this study. The mechanisms of differential
regulation of the two non-allelic th forms need further
investigation. A mutant for th2 could be beneficial in order to
understand the precise function of th2 in the brain.
In pink1 morphant larvae, the pink1 mRNA could rescue the
detrimental effects caused by the knockdown. When LGR was
added, in addition to the pink1 mRNA, the rescue effect was
clearly enriched. LGR is a thiol antioxidant and protects cells
from various cytotoxic insults, as indicated in a study
conducted on rabbits [14]. Glutathione is administered in the
reduced form, as it can more easily cross the cell membrane
than glutathione itself [44]. It has also been shown that the
level of glutathione within the cell is quite critical for the cellular
redox balance [14]. This provides suitable evidence that PINK1
and glutathione might operate on the same pathways. The
present study contributes to our understanding of the
mechanism of PD pathogenesis in the oxidative stress-
mediated pathway.
Conclusions
This study suggests that PINK1 activity could potentially
serve as a valid target for neuroprotection in PD. The drug L-
Glutathione Reduced could effectively normalize the decline in
th2 and th1 expression in the pink1 morphants and it could also
recover the altered levels of th2 and pink1 in the groups
subjected to H2O2 in the oxidative stress model. This protective
effect of glutathione on the dopaminergic system may prove
significant for drug development targeted at the early phases of
degenerative diseases such as PD. The zebrafish is now
emerging as an alternative for modeling human disease and
drug discovery [45,46]. The development of the
Tg(pink1:EGFP) zebrafish has provided a useful tool for drug
screening and the mechanistic analysis of oxidative damage in
the central nervous system as a whole, in addition to analysis
of the dopaminergic system and PD mechanisms. The
Tg(pink1:EGFP) line potentially responds to subtle changes in
the external environment and this makes it a valuable tool for
study of environmental stressors on pink1 gene function.
Supporting Information
Figure S1.  Comparison of the GFP expression pattern with
TH-ir and 5-HT-ir in Tg(pink1:EGFP) fish at 7 dpf. D-F. TH ir
compared to GFP distribution in the Tg(pink1:EGFP) fish. GFP
is more widely distributed than TH-ir. A ventral view of the
maximum projection images for TH and GFP. The cell
populations and numbering are as in [28].
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G-I. The 5-HT-ir is colocalized with GFP expression in the
posterior recess of the paraventricular organ (arrowhead).
5-HT – 5-hydroxy tryptophan, TH – tyrosine hydroxylase, ir –
immunoreactivity, GFP – Green fluorescent protein, PVOa –
paraventricular organ anterior part, PVOi – paraventricular
organ intermediate part, PVOp – paraventricular organ
posterior part.
Scale bar represents 100 μm.
(TIF)
Figure S2.  A. Schematic lateral view of pink1:egfp expressing
regions in the zebrafish brain compiled from
immunohistochemistry of larval and adult brain sections. The
regions are marked as: Tel – telencephalon, Teo – anterior
region of the optic tectum, Hy – hypothalamus, rho –
rhombencephalon.
B-E. Cryosections of different regions of the adult zebrafish
brain with immunoreactivity detected for TH (red), PINK1 (blue)
and pink1:egfp (green). The cell populations of TH-ir are
reported with numbers, and additional regions of GFP are
marked with dotted lines.
Di – lateral zone of the dorsal telencephalon, ENd –
endopeduncular nucleus, VOT – ventrolateral optic tract, TeO –
tectum opticum, PTN – posterior tuberal nucleus, Hc – caudal
zone of the periventricular hypothalamus, LCa – lobus caudalis
cerebelli, ALLN – anterior lateral line nerves.
Scale bar represents 100 μm.
(TIF)
Figure S3.  The transcript levels of dat in WT and H2O2-
treated fish. A. Larval groups measured by q-RT-PCR. No
significant level of transcript alteration was visualized amongst
the groups.
B. No change in expression levels between the two groups was
also observed by ISH.
Scale bar represents 100 µm.
(TIF)
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